227 related articles for article (PubMed ID: 19136084)
1. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.
Sundaram S; Diaz JP; González-Quintero VH; Verma U
Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
Kapp N; Todd CS; Yadgarova KT; Alibayeva G; Nazarova D; Loza O; Babadjanova GS
Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
4. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
Zou LY; Fan L
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
[TBL] [Abstract][Full Text] [Related]
5. Intervention rates for placental removal following induction abortion with misoprostol.
Green J; Borgatta L; Sia M; Kapp N; Saia K; Carr-Ellis S; Vragovic O
Contraception; 2007 Oct; 76(4):310-3. PubMed ID: 17900443
[TBL] [Abstract][Full Text] [Related]
6. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Verhulsdonk MT; Papatsonis DN; Heydanus R
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
Daskalakis GJ; Mesogitis SA; Papantoniou NE; Moulopoulos GG; Papapanagiotou AA; Antsaklis AJ
BJOG; 2005 Jan; 112(1):97-9. PubMed ID: 15663405
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol.
Pongsatha S; Tongsong T
J Obstet Gynaecol Res; 2004 Jun; 30(3):217-20. PubMed ID: 15210046
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens.
Edwards RK; Sims SM
Am J Obstet Gynecol; 2005 Aug; 193(2):544-8; author reply 548-50. PubMed ID: 16098889
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy.
Su LL; Biswas A; Choolani M; Kalaichelvan V; Singh K
Am J Obstet Gynecol; 2005 Oct; 193(4):1410-4. PubMed ID: 16202734
[TBL] [Abstract][Full Text] [Related]
12. Rectal misoprostol in management of retained placenta: a contradictory result.
Pongsatha S; Tongsong T
J Med Assoc Thai; 2011 May; 94(5):535-9. PubMed ID: 21675440
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol.
Perry KG; Rinehart BK; Terrone DA; Martin RW; May WL; Roberts WE
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1057-61. PubMed ID: 10561618
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
[TBL] [Abstract][Full Text] [Related]
16. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Stoutjesdijk JA; Alsma J; Wildschut HI
Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
[TBL] [Abstract][Full Text] [Related]
17. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study.
Leader J; Bujnovsky M; Carlan SJ; Triana T; Richichi K
Obstet Gynecol; 2002 Oct; 100(4):689-94. PubMed ID: 12383535
[TBL] [Abstract][Full Text] [Related]
19. Optimization of third-stage management after second-trimester medical pregnancy termination.
Dickinson JE; Doherty DA
Am J Obstet Gynecol; 2009 Sep; 201(3):303.e1-7. PubMed ID: 19632665
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
